Zimmer Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) filed this Current Report on Form 8-K on April 26, 2012. The filing reports the company's results of operations for the quarter ended March 31, 2012. The detailed financial data is contained in the attached earnings release (Exhibit 99.1), which is incorporated by reference.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the referenced Exhibit 99.1 press release. The filing notes the use of two types of non-GAAP financial measures:
- Constant Currency Sales: Sales translated at predetermined exchange rates to exclude foreign currency fluctuations.
- Adjusted Operating Performance: Adjusted net earnings and diluted EPS excluding inventory step-up and special items (net of tax).
Special items excluded from adjusted measures include acquisition and integration costs, employee termination benefits, consulting fees, litigation matters, and asset impairment charges related to global restructuring.
Material Changes
The filing does not explicitly state the magnitude of changes versus the prior period within the text of the 8-K. It directs investors to the attached press release for year-over-year percentage increases or decreases and trend analysis.
Guidance, Outlook, and Management Commentary
Management utilizes the non-GAAP adjusted diluted EPS as a performance metric for incentive compensation programs. The company asserts that these adjusted measures provide a clearer view of ongoing operating results and trends by masking distortions from special items. The filing does not contain specific forward-looking guidance numbers or detailed risk contingencies in the text provided; these are expected to be in the attached press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific GAAP and non-GAAP revenue, net earnings, and EPS figures for the quarter ended March 31, 2012.
- Verify the reconciliation between non-GAAP adjusted measures and GAAP financial measures as required by the filing.
- Examine the specific dollar amounts attributed to "special items" such as restructuring charges and litigation costs.
- Confirm the impact of foreign currency exchange rates on reported sales growth.